Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

A global trial finds Wegovy and Ozempic significantly improve liver health in patients and treats those with advanced fatty ...

Though popular weight loss jabs like Ozempic and Wegovy have been deemed safe and effective by the FDA, concerning side ...

Ozempic may improve fertility if you have PCOS. In a 2023 study, 27 women with obesity and PCOS took a weekly 0.5-milligram ...

The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new clinical trial has ...

An analysis of emergency visits related to the active ingredient in drugs like Ozempic and Wegovy have exposed a surprising ...

A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

Of the total ER visits, nearly 70% involved GI issues, 15% of which led to hospitalization, according to a new study.